JASPER THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On January 18, 2023, Jasper Therapeutics, Inc. (the "Company") received a letter from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained full compliance with the minimum bid price requirement of the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), which requires that the Company maintain a minimum bid price of $1.00 per share. The Company regained compliance after the closing bid price of the Company's voting common stock had been at $1.00 per share or greater for ten consecutive business days, from January 3, 2023 through January 17, 2023.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



104       Cover Page Interactive Data File, formatted in Inline Extensible
          Business Reporting Language (iXBRL).




                                       1

© Edgar Online, source Glimpses